Sina Jasim

Medicine & Life Sciences

1. Adrenocortical Carcinoma 53%
2. alpha-Methyltyrosine 27%
3. Bone Diseases 22%
4. Cancer Survivors 64%
5. Checklist 19%
6. Confidence Intervals 23%
7. Databases 17%
8. Endocrinologists 55%
9. Endocrinology 46%
10. Fine Needle Biopsy 25%
11. Goiter 22%
12. Growth Hormone 56%
13. Guidelines 16%
14. Hypopituitarism 50%
15. Insulin-Like Growth Factor Binding Protein 3 24%
16. Insulin-Like Growth Factor I 19%
17. Iodine 30%
18. lenvatinib 27%
19. Lipid A 26%
20. Local Anesthetics 20%
21. Lymphoma 16%
22. Medullary Thyroid cancer 29%
23. Meta-Analysis 77%
24. Multiple Endocrine Neoplasia Type 2b 31%
25. Muscular Diseases 21%
26. Neoplasms 37%
27. Off-Label Use 26%
28. Osteosclerosis 29%
29. Paraganglioma 75%
30. Parathyroidectomy 49%
31. pazopanib 29%
32. Pheochromocytoma 68%
33. Pituitary Neoplasms 21%
34. Practice Guidelines 22%
35. Primary Hyperparathyroidism 47%
36. Proto-Oncogenes 23%
37. Quality of Life 21%
38. Radiotherapy 17%
39. Recurrence 17%
40. Survivors 17%
41. Systematic Reviews 82%
42. Tertiary Care Centers 17%
43. Testosterone 17%
44. Therapeutics 29%
45. Thyroid Diseases 16%
46. Thyroid Gland 64%
47. Thyroid Hormones 22%
48. Thyroid Neoplasms 100%
49. Thyroid Nodule 49%
50. Watchful Waiting 22%